Literature DB >> 11277132

Early rehabilitation of head-neck edema after curative surgery for orofacial tumors.

D U Piso1, A Eckardt, A Liebermann, C Gutenbrunner, P Schäfer, A Gehrke.   

Abstract

OBJECTIVE: To evaluate a rehabilitative program for postoperative head-neck edema.
DESIGN: Eleven patients completed the study. A series of ten manual lymphatic drainage were initiated and completed early after surgery. On discharge from the hospital, the patients wore "made-to-measure" or customized compression garments for the next several weeks. Tape measurements and sonographic evaluation of the soft-tissue width were used to quantify the extent of the swelling.
RESULTS: After 6 wk of therapy, the patients exhibited a statistically significant (P < 0.05; Wilcoxon's test) remission; the remission continued in eight patients who were measured at 12+/-3 wk.
CONCLUSIONS: This initial trial demonstrates that sequential therapy of manual lymphatic drainage and compression garments can significantly reduce early postoperative edema after curative surgery for orofacial tumors. The outcome can be quantified by comparing the course of distances between the defined anatomic marks and by sonographic evaluation of soft-tissue width. This pilot study encourages that more controlled, randomized studies, with larger numbers of patients, be conducted to verify these results.

Entities:  

Mesh:

Year:  2001        PMID: 11277132     DOI: 10.1097/00002060-200104000-00006

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  11 in total

1.  Preliminary development of a lymphedema symptom assessment scale for patients with head and neck cancer.

Authors:  Jie Deng; Sheila H Ridner; Barbara A Murphy; Mary S Dietrich
Journal:  Support Care Cancer       Date:  2011-11-10       Impact factor: 3.603

2.  Lymphedema outcomes in patients with head and neck cancer.

Authors:  Brad G Smith; Katherine A Hutcheson; Leila G Little; Roman J Skoracki; David I Rosenthal; Stephen Y Lai; Jan S Lewin
Journal:  Otolaryngol Head Neck Surg       Date:  2014-11-11       Impact factor: 3.497

Review 3.  [Surgical therapy of secondary elephantoid lymphedema of the eyelids].

Authors:  A Sandner; A Lindner
Journal:  HNO       Date:  2015-01       Impact factor: 1.284

Review 4.  Lymphedema management in head and neck cancer.

Authors:  Brad G Smith; Jan S Lewin
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-06       Impact factor: 2.064

5.  A multimodal physical therapy approach to the management of a patient with temporomandibular dysfunction and head and neck lymphedema: a case report.

Authors:  Patricia Crane; Lauren Feinberg; John Morris
Journal:  J Man Manip Ther       Date:  2015-02

6.  Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life.

Authors:  Jie Deng; Barbara A Murphy; Mary S Dietrich; Nancy Wells; Kenneth A Wallston; Robert J Sinard; Anthony J Cmelak; Jill Gilbert; Sheila H Ridner
Journal:  Head Neck       Date:  2012-07-12       Impact factor: 3.147

Review 7.  Rehabilitation and quality-of-life issues in patients with extremity soft tissue sarcoma.

Authors:  Janet A Parsons; Aileen M Davis
Journal:  Curr Treat Options Oncol       Date:  2004-12

8.  Usability of advanced pneumatic compression to treat cancer-related head and neck lymphedema: A feasibility study.

Authors:  Harvey N Mayrovitz; Shelly Ryan; James M Hartman
Journal:  Head Neck       Date:  2017-11-13       Impact factor: 3.147

9.  Translation and adaptation to Brazilian Portuguese of the Lymphedema Rating Scale in Head and Neck Cancer.

Authors:  Débora Dos Santos Queija; Lica Arakawa-Sugueno; Bruna Mello Chamma; Marco Aurélio Vamondes Kulcsar; Rogério Aparecido Dedivitis
Journal:  Einstein (Sao Paulo)       Date:  2017-12-18

10.  A comprehensive review of head and neck cancer rehabilitation: physical therapy perspectives.

Authors:  Karthikeyan Guru; Udaya Kumar Manoor; Sanjay Sudhakar Supe
Journal:  Indian J Palliat Care       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.